Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYCLOPHARM LIMITED Director's Dealing 2017

Jul 3, 2017

64741_rns_2017-07-03_31cb4e72-ceb0-4f26-b05a-1f7bdede542f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CYCLOPHARM LIMITED ABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director Vanda Russell Gould
Date of last notice 31/05/2017

Part 1 ‐ Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest French Park Investments Pty Ltd (director)
(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. French Park Investments Pty Ltd (SheanFamily Super Fund A/c) (director)
Mrs Debbie Anne Gould (spouse)
Leagou Pty Limited (director)
MalackeyHoldingsPtyLtd(alternate
director)
Melbourne Corp of Australia Pty Ltd
(director)
Melbourne Corporation of Australia Pty Ltd
(Superannuation Fund A/c) (director)
South Seas Holdings Pty Limited (director)
Chemical Trustee Limited (related party*)
Date of change 30/6/2017
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change No. of securities held prior to change No. of securities held prior to change French Park Investments Pty Ltd 60,730French Park Investments Pty Ltd (SheanFamily Super Fund A/c) 140,000Mrs Debbie Anne Gould 5000 French Park Investments Pty Ltd 60,730French Park Investments Pty Ltd (SheanFamily Super Fund A/c) 140,000Mrs Debbie Anne Gould 5000 French Park Investments Pty Ltd 60,730French Park Investments Pty Ltd (SheanFamily Super Fund A/c) 140,000Mrs Debbie Anne Gould 5000 French Park Investments Pty Ltd 60,730French Park Investments Pty Ltd (SheanFamily Super Fund A/c) 140,000Mrs Debbie Anne Gould 5000
Leagou Pty Limited 5,10Malacke Holdins Pt L ,0td 350000
y g yMelbourne Corp of Aust ,ralia Pty Ltd 340,000
Melbourne Corporation of Australia Pty Ltd
(Superannuation Fund A /c) 865,469
South Seas Holdings Pty Limited 575,000*
Chemical Trustee Limi8000000 ed (related party)
,,Total shares 10,341,299
Class Ordinary Shares
Number acquired 1590015
,,
Number disposed Nil
Value/Consideration $1272012
Note: If consideration is non‐cash, provide details and estim ated ,,
valuation
No. of securities held after change French Park InvestmentsFrench Park Investme Pty Ltd 69,660nts Pty Ltd (Shean
Family Super Fund A/c)Mrs Debbie Anne GouldLeagou Pty Limited 6,00 60,5886,0000
Malackey Holdings Pty L td 420,220
Melbourne Corp of Aust ralia Pty Ltd 400,000
Melbourne Corporation(Superannuation Fund ASouth Seas Holdins Pt of Australia Pty Ltd/c) 1,017,376Limited 675000
g yChemical Trustee Limit ,ed (related party*)
9,176,470Total shares 11,931,314
Nature of change Issue of shares unde r non‐renounceable
Example: on‐market trade, off‐market trade, exercise of optiissue of securities under dividend reinvestment plan, participatio ons,n in entitlement offer
buy‐back Note (*) On 25 Nove ber 2016 Mr Gould
:notified the market that ,despite the fact that
he believed he did no t have the requisite
control to constitute r elevant interests in
Chemical Trustee Limit ed, as an advisor to
this entity, he haditt i th h eclared a relevant
neres n ose sares.
S ht f dfid t
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil
Nature of interest Nil
Name of registered holder(if issued securities) Nil
Date of change Nil
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract inrelation to which the interest has changed Nil
Interest acquired Nil
Interest disposed Nil
Value/ConsiderationNote: If consideration is non‐cash, provide detailsand an estimated valuation Nil
Interest after change Nil

Part 3 –[+] Closed period

Were the interests in the securities or contractsdetailed above traded during a+closed periodwhere prior written clearance was required? No
If so, was prior written clearance provided to allowthe trade to proceed during this period? Not Applicable
If prior written clearance was provided, on whatdate was this provided? Not Applicable
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3